Hutchison China Meditech Ltd is a major drug manufacturing company. The company operates two platforms--an innovation platform and a commercial platform. Hutchison’s innovation platform focuses on discovering and developing therapeutics in oncology and autoimmune diseases. The company’s commercial platform includes the manufacturing, marketing, and distribution of prescription and over-the-counter pharmaceuticals in China as well as certain consumer products in Hong Kong. The vast majority of the company’s revenue is generated through its commercial platform.